News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
New webinar series by ESMO on precision medicine recommendations
Photo taken from ESMO - Eur. Oncology/Twitter
Oct 15, 2023, 17:35

New webinar series by ESMO on precision medicine recommendations

The European Society for Medical Oncology (ESMO) shared on Twitter:

Stay updated with the latest ESMO recommendations on precision medicine for optimal integration into daily care with this new webinar series.

To register click here.
Source: ESMO – Eur. Oncology/Twitter

cancer ESMO OncoDaily Oncology Precision Medicine Twitter
Insight
Aug 18, 2024, 01:43
Steven D Wexner: SEER database analysis of predictors of LN metastasis in neuroendocrone tumors
Blog
Aug 17, 2024, 08:58
Neha Mehta-Shah: Wonderful St. Louis tradition of the arts bringing together community!
Blog
Aug 17, 2024, 20:44
Palliative care is an added layer of support - Kidney CAN
Blog
Aug 17, 2024, 20:40
Register for HTTR24 - IASLC
Blog
Aug 17, 2024, 20:35
Nominate a colleague for a Fondazione Pezcoller - European Association for Cancer Research Award
Insight
Aug 17, 2024, 20:27
Andrea Carai: Our data suggest that VR is overall useful for pediatric neurosurgical oncology
Blog
Aug 17, 2024, 20:21
Dunkley’s will be lacing up their walking shoes for the Shine Night Walk in Bristol in support of Cancer Research UK - Dunkley's Chartered Accountants
Blog
Aug 17, 2024, 20:10
CANCaRe Africa's Voice of the families: Gashanew and his father
Blog
Aug 17, 2024, 20:07
Roche Africa CEO recently spoke of the care gap that exists throughout the African continent
Blog
Aug 17, 2024, 20:01
Miriam Mutebi: Cancer fatalism—the belief that cancer is incurable
Insight
Aug 17, 2024, 19:56
Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus
Blog
Aug 17, 2024, 19:53
First European Patient Dosed in Phase I Trial Of Novel CD30-Directed ADC FOR Lymphomas - The START Center for Cancer Research